Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT06206369

Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression

Conditions: Aneurysm Abdominal, Peripheral Arterial Disease

Sex: All
Ages: 40 Years – 90 Years
Healthy volunteers: No
Enrollment: 11000
Sponsor: Amsterdam UMC, location VUmc

Location: Hospital District of Helsinki and Uusimaa (HUS) Helsinki

Summary

The VASCULAID-RETRO study, within the broader VASCULAID project, aims to create artificial intelligence (AI) algorithms that can predict cardiovascular events and the progression of abdominal aortic aneurysm (AAA) and peripheral arterial disease (PAD). The study plans to gather and analyze data from at least 5000 AAA and 6000 PAD patients, combining existing cohorts and retrospectively collected data. During this project, AI tools will be developed to perform automatic anatomical segmentation and analyses on multimodal imaging. AI prediction algorithms will be developed based on multisource data (imaging, medical history, -omics).

Eligibility Criteria

Inclusion Criteria AAA: * Males and females * 40-90 years old, * Infrarenal, juxtarenal, suprarenal, iliac aneurysms (defined as 1.5x its normal diameter), and mycotic aneurysms. * Starting AAA diameter \>3cm, * Patients that both have had or did not have interventions or ruptures. Exclusion Criteria AAA: * Patients with solely an ascending, thoracic, thoracoabdominal (type 1-3) aneurysm. Inclusion Criteria PAD: * Males and females, * 40-90 years old, * All PAD patients; all Fontaine stages 1,2,3, and 4. Exclusion Criteria PAD: None

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06206369). StuddyBuddy aggregates publicly available trial information.